Literature DB >> 23110861

Bilirubin, the gold within.

Jurgen Seppen, Piter Bosma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23110861     DOI： 10.1161/CIRCULATIONAHA.112.147082

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  4 in total

1.  Bilirubin as a potential causal factor in type 2 diabetes risk: a Mendelian randomization study.

Authors:  Ali Abbasi; Petronella E Deetman; Eva Corpeleijn; Ron T Gansevoort; Rijk O B Gans; Hans L Hillege; Pim van der Harst; Ronald P Stolk; Gerjan Navis; Behrooz Z Alizadeh; Stephan J L Bakker
Journal:  Diabetes       Date:  2014-11-03       Impact factor: 9.461

2.  Circulating total bilirubin and risk of non-alcoholic fatty liver disease in the PREVEND study: observational findings and a Mendelian randomization study.

Authors:  Setor K Kunutsor; Monika Frysz; Niek Verweij; Lyanne M Kieneker; Stephan J L Bakker; Robin P F Dullaart
Journal:  Eur J Epidemiol       Date:  2019-11-26       Impact factor: 8.082

3.  Lineage-Specific Changes in Biomarkers in Great Apes and Humans.

Authors:  Claudius Ronke; Michael Dannemann; Michel Halbwax; Anne Fischer; Christin Helmschrodt; Mathias Brügel; Claudine André; Rebeca Atencia; Lawrence Mugisha; Markus Scholz; Uta Ceglarek; Joachim Thiery; Svante Pääbo; Kay Prüfer; Janet Kelso
Journal:  PLoS One       Date:  2015-08-06       Impact factor: 3.240

4.  Circulating Total Bilirubin and Future Risk of Hypertension in the General Population: The Prevention of Renal and Vascular End-Stage Disease (PREVEND) Prospective Study and a Mendelian Randomization Approach.

Authors:  Setor K Kunutsor; Lyanne M Kieneker; Stephen Burgess; Stephan J L Bakker; Robin P F Dullaart
Journal:  J Am Heart Assoc       Date:  2017-11-13       Impact factor: 5.501
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.